HistCite - [title] Word list:

Ranked [title] Word list

Mon Aug 28 12:20:36 2006

A gain-of-function mutation of JAK2 in myeloproliferative disorders
Kralovics R, Passamonti F, Buser AS, Teo S, Tiedt R, et al.
NEW ENGLAND JOURNAL OF MEDICINE 352 (17): 1779-1790 APR 28 2005
and the citing papers

stopwords, and 2-character and smaller words are excluded, Word count: 1525, All words count: 2266
Grand TLCS: 663, Grand TGCS: 901

View: Overview

Sorted by number of publications (Pubs).

Page 1 of 3: [ 1 2 3 ]

#	Word	Pubs	TLCS	TGCS
1	JAK	75	539	625
2	MUTATION	66	534	618
3	MYELOPROLIFERATIVE	51	411	480
4	V617F	49	267	337
5	DISORDERS	47	407	477
6	VERA	28	101	116
7	CHRONIC	26	124	153
8	POLYCYTHEMIA	25	87	92
9	ESSENTIAL	21	62	91
10	MYELOFIBROSIS	19	25	34
11	THROMBOCYTHEMIA	19	26	40
12	LEUKEMIA	16	48	61
13	MYELOID	16	43	74
14	KINASE	15	94	131
15	PATIENTS	15	10	14
16	TYROSINE	15	93	181
17	CLINICAL	14	57	85
18	MOLECULAR	13	48	71
19	DIAGNOSIS	11	15	28
20	ACTIVATING	10	70	88
21	ANALYSIS	10	15	19
22	ACUTE	9	49	66
23	ACTIVATION	8	26	31
24	ASSOCIATED	8	9	10
25	CELLS	8	8	8
26	IDIOPATHIC	8	4	5
27	EXPRESSION	7	35	40
28	IMPLICATIONS	7	32	59
29	KINASES	7	12	85
30	PATHOGENESIS	7	11	12
#	Word	Pubs	TLCS	TGCS
31	THROMBOSIS	7	7	9
32	ACQUIRED	6	60	67
33	BONE	6	5	6
34	DISEASES	6	1	1
35	FEATURES	6	6	7
36	JAK2V617F	6	26	32
37	MARROW	6	5	6
38	METAPLASIA	6	11	16
39	STATUS	6	37	56
40	DETECTION	5	4	6
41	HUMAN	5	0	4
42	MALIGNANCIES	5	11	29
43	MANAGEMENT	5	0	1
44	MUTATIONS	5	3	5
45	MYELODYSPLASTIC	5	55	70
46	NEW	5	0	0
47	POLYCYTHAEMIA	5	30	43
48	ROLE	5	3	3
49	SIGNALING	5	10	19
50	STAT	5	2	3
51	SYNDROME	5	0	1
52	BUDD-CHIARI	4	0	1
53	CLASSIC	4	10	12
54	CLASSIFICATION	4	17	28
55	CLONAL	4	2	2
56	DISEASE	4	18	32
57	ERYTHROID	4	5	5
58	ERYTHROPOIETIN	4	0	3
59	FLT	4	1	2
60	HOMOZYGOUS	4	11	16
#	Word	Pubs	TLCS	TGCS
61	OCCURS	4	20	25
62	PLATELET	4	3	8
63	RECEPTOR	4	23	30
64	SYNDROMES	4	55	70
65	THERAPY	4	3	54
66	TREATMENT	4	1	3
67	UNCOMMON	4	12	12
68	ASSAYS	3	2	3
69	ATYPICAL	3	50	63
70	BASIS	3	8	8
71	CANCER	3	3	54
72	CELL	3	13	18
73	COLONY	3	2	2
74	CONTROL	3	8	13
75	CORRELATION	3	3	3
76	DIAGNOSTIC	3	4	5
77	FACTOR	3	1	3
78	FIBROSIS	3	0	0
79	FORMATION	3	2	2
80	GENE	3	10	16
81	HEMATOLOGICAL	3	1	2
82	HEMATOPOIETIC	3	2	2
83	IDENTIFICATION	3	59	60
84	INCREASED	3	5	5
85	INSIGHTS	3	3	3
86	JANUS	3	6	11
87	LEUKAEMIA	3	7	8
88	LEUKEMIAS	3	26	37
89	LONG-TERM	3	20	27
90	LYMPHOMA	3	0	0
#	Word	Pubs	TLCS	TGCS
91	MYELOGENOUS	3	3	4
92	MYELOMONOCYTIC	3	24	29
93	PHOSPHORYLATION	3	0	4
94	PRESENCE	3	1	2
95	PRIMARY	3	0	1
96	PRV	3	14	17
97	SECONDARY	3	14	18
98	THROMBOCYTHAEMIA	3	36	51
99	THROMBOPOIETIN	3	7	12
100	TRANSLOCATION	3	0	0
101	ABSENCE	2	0	0
102	ABSENT	2	0	0
103	ACTIVATED	2	0	0
104	ADVANCES	2	6	8
105	AKT	2	0	15
106	ALPHA	2	1	2
107	ASSOCIATION	2	2	7
108	B-CELL	2	0	0
109	BCR	2	1	3
110	BIOPSIES	2	1	2
111	BLEEDING	2	3	5
112	CAUSES	2	4	4
113	CHROMOSOMAL	2	5	6
114	CHROMOSOME-NEGATIVE	2	23	28
115	CLINICOPATHOLOGIC	2	0	0
116	CLINICOPATHOLOGICAL	2	0	1
117	CML	2	23	29
118	COEXPRESSION	2	2	2
119	CONSTITUTIVE	2	4	4
120	CORRELATES	2	21	27
#	Word	Pubs	TLCS	TGCS
121	CRITERIA	2	0	1
122	CRITICAL	2	3	4
123	CURRENT	2	6	7
124	CURVE	2	1	2
125	DEVELOPMENT	2	0	0
126	DIFFERENT	2	2	2
127	DOMAIN	2	0	0
128	ENDOGENOUS	2	2	2
129	ENDOTHELIAL	2	0	0
130	ERYTHROCYTOSIS	2	4	5
131	ETIOLOGY	2	2	3
132	EVOLUTION	2	0	0
133	EXPANSION	2	0	0
134	FACTORS	2	1	2
135	FAMILIAL	2	6	7
136	FOUND	2	26	32
137	FREQUENTLY	2	0	0
138	GENETIC	2	0	0
139	GROWTH	2	1	2
140	HEMATOLOGIC	2	0	5
141	HEMATOPOIESIS	2	2	2
142	HETEROZYGOUS	2	5	5
143	HIGH-THROUGHPUT	2	0	0
144	HYDROXYUREA	2	0	0
145	IDENTIFIES	2	2	2
146	IMATINIB	2	1	3
147	INCIDENCE	2	0	0
148	LEADING	2	0	0
149	LEVELS	2	0	0
150	LIGHTCYCLER	2	0	1
#	Word	Pubs	TLCS	TGCS
151	LYMPHOBLASTIC	2	21	27
152	MDS	2	5	7
153	MECHANISMS	2	3	8
154	MELTING	2	1	2
155	MOUSE	2	0	0
156	MUTATIONAL	2	3	3
157	MYB	2	0	0
158	NEUTROPHILIC	2	2	2
159	NOVO	2	4	5
160	ONCOGENIC	2	1	1
161	PATHOLOGICAL	2	4	4
162	PATHWAY	2	0	3
163	PERSPECTIVES	2	0	0
164	PHENOTYPE	2	5	5
165	PHILADELPHIA	2	23	28
166	PLATELETS	2	0	0
167	POINT	2	0	0
168	PROGNOSTIC	2	20	27
169	PROSPECTIVE	2	16	25
170	PROTEIN	2	0	5
171	PROTEOMICS	2	0	4
172	QUANTITATIVE	2	3	3
173	RARE	2	24	29
174	RELATION	2	20	29
175	RELEVANCE	2	19	25
176	REPLY	2	0	0
177	REPORT	2	15	25
178	RESISTANCE	2	1	2
179	RESPONSE	2	1	2
180	RISK	2	1	1
#	Word	Pubs	TLCS	TGCS
181	SCIENTIFIC	2	14	16
182	SCREENING	2	13	17
183	SENSITIVE	2	0	0
184	SERIES	2	1	1
185	SERUM	2	0	0
186	SIGNAL	2	2	3
187	SOMATIC	2	0	0
188	STEM	2	2	2
189	SUBSET	2	7	9
190	SYSTEM	2	0	1
191	TARGETS	2	3	66
192	TEST	2	5	7
193	THERAPEUTIC	2	10	12
194	TRANSDUCTION	2	2	3
195	TREPHINE	2	1	2
196	TRUE	2	0	0
197	UPDATE	2	0	0
198	USING	2	1	2
199	VAL617PHE	2	2	2
200	VIVO	2	1	1

Page 1 of 3: [ 1 2 3 ]